Cost-Effectiveness of Switching to the Nonavale...

By Rene Pretorius

January 13, 2025

A recent study on the cost-effectiveness of transitioning from the bivalent human papillomavirus vaccine (2vHPV) to the nonavalent vacci...
GLP-1 Receptor Agonists: Balancing Benefits and Risks in Treatment Decisions
Promising Dual Immunotherapy for Anaplastic Thyroid Cancer
Valuable, Cost-Effective Thyroid Cancer Diagnosis
WHO Prequalifies First G6PD Diagnostic Test
Cultural Challenges Hindering AI in Maternal Healthcare in Africa
Advancing Newborn Screening for Sickle Cell Disease in Africa
Diabetes Drugs Safe from Thyroid Cancer Risk, Study Finds
Abu Dhabi Introduces WINREVAIR: A Major Breakthrough in Pulmonary Arterial Hy...
Thyroid Eye Disease Therapy: Insights from Viridian Therapeutics’ THRIV...
Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prev...
Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak
BioSapien Innovative Cancer Drug Delivery Solutions